The Comparative Study on the Status of Bone Metabolism and Thyroid Function in Diabetic Patients with or without Ketosis or Ketoacidosis

References

• Sealand R, Razavi C, Adler RA. Diabetes mellitus and osteoporosis. Curr Diab Rep. 2013;13(3):411–418. doi:10.1007/s11892-013-0376-x
   PubMed Web of Science ®Google Scholar
• Napoli N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL. Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol. 2017;13(4):208–219. doi:10.1038/nrendo.2016.153
   PubMed Web of Science ®Google Scholar
• Jain S. Role of bone turnover markers in osteoporosis therapy. Endocrinol Metab Clin North Am. 2021;50(2):223–237. doi:10.1016/j.ecl.2021.03.007
   PubMed Web of Science ®Google Scholar
• Zoch ML, Clemens TL, Riddle RC. New insights into the biology of osteocalcin. Bone. 2016;82:42–49. doi:10.1016/j.bone.2015.05.046
   PubMed Web of Science ®Google Scholar
• Mizokami A, Yasutake Y, Gao J, et al. Osteocalcin induces release of glucagon-like peptide-1 and thereby stimulates insulin secretion in mice. PLoS One. 2013;8(2):e57375. doi:10.1371/journal.pone.0057375
   PubMed Web of Science ®Google Scholar
• Mizokami A, Yasutake Y, Higashi S, et al. Oral administration of osteocalcin improves glucose utilization by stimulating glucagon-like peptide-1 secretion. Bone. 2014;69:68–79. doi:10.1016/j.bone.2014.09.006
   PubMed Web of Science ®Google Scholar
• Rached MT, Kode A, Silva BC, et al. FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice. J Clin Invest. 2010;120(1):357–368. doi:10.1172/JCI39901
   PubMed Web of Science ®Google Scholar
• Riddle RC, Frey JL, Tomlinson RE, et al. Tsc2 is a molecular checkpoint controlling osteoblast development and glucose homeostasis. Mol Cell Biol. 2014;34(10):1850–1862. doi:10.1128/MCB.00075-14
   PubMed Web of Science ®Google Scholar
• Garbossa SG, Folli F. Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism. Rev Endocr Metab Disord. 2017;18(2):243–258. doi:10.1007/s11154-017-9423-2
   PubMed Web of Science ®Google Scholar
• Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92(6):2017–2029. doi:10.1210/jc.2007-0298
   PubMed Web of Science ®Google Scholar
• Mera P, Ferron M, Mosialou I. Regulation of energy metabolism by bone-derived hormones. Cold Spring Harb Perspect Med. 2018;8(6):a031666. doi:10.1101/cshperspect.a031666
   Web of Science ®Google Scholar
• Mitri J, Dawson-Hughes B, Hu FB, Pittas AG. Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr. 2011;94(2):486–494. doi:10.3945/ajcn.111.011684
   PubMed Web of Science ®Google Scholar
• Wei W, Jiang W, Gu W, et al. The joint effect of energy reduction with calcium supplementation on the risk factors of type 2 diabetes in the overweight population: a two-year randomized controlled trial. Aging. 2021;13(4):5571–5584. doi:10.18632/aging.202485
   Google Scholar
• Gagnon C, Daly RM, Carpentier A, et al. Effects of combined calcium and vitamin D supplementation on insulin secretion, insulin sensitivity and β-cell function in multi-ethnic vitamin D-deficient adults at risk for type 2 diabetes: a pilot randomized, placebo-controlled trial. PLoS One. 2014;9(10):e109607. doi:10.1371/journal.pone.0109607
   Web of Science ®Google Scholar
• Ryu OH, Lee S, Yu J, Choi MG, Yoo HJ, Mantero F. A prospective randomized controlled trial of the effects of vitamin D supplementation on long-term glycemic control in type 2 diabetes mellitus of Korea. Endocr J. 2014;61(2):167–176. doi:10.1507/endocrj.EJ13-0356
   Web of Science ®Google Scholar
• Walter M, Kaupper T, Adler K, Foersch J, Bonifacio E, Ziegler AG. No effect of the 1alpha,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes. Diabetes Care. 2010;33(7):1443–1448. doi:10.2337/dc09-2297
   PubMed Web of Science ®Google Scholar
• Kalra S, Aggarwal S, Khandelwal D. Thyroid dysfunction and type 2 diabetes mellitus: screening strategies and implications for management. Diabetes Ther. 2019;10(6):2035–2044. doi:10.1007/s13300-019-00700-4
   PubMed Web of Science ®Google Scholar
• Liu Q, Yang Z, Xie C, et al. The hyperglycemia and hyperketonemia impaired bone microstructures: a pilot study in rats. Front Endocrinol. 2020;11:590575. doi:10.3389/fendo.2020.590575
   Web of Science ®Google Scholar
• Gosmanov AR, Gosmanova EO, Kitabchi AE, et al. Hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc.Copyright © 2000–2021, MDText.com, Inc.; 2000.
   Google Scholar
• Umpierrez GE, Smiley D, Kitabchi AE. Narrative review: ketosis-prone type 2 diabetes mellitus. Ann Intern Med. 2006;144(5):350–357. doi:10.7326/0003-4819-144-5-200603070-00011
   PubMed Web of Science ®Google Scholar
• Sjöholm Å:. Ketosis-prone type 2 diabetes: a case series. Front Endocrinol. 2019;10:684. doi:10.3389/fendo.2019.00684
   Web of Science ®Google Scholar
• Zhang M, Li Y, Cui W, et al. The clinical and metabolic characteristics of young-onset ketosis-prone type 2 diabetes in China. Endocr Pract. 2015;21(12):1364–1371. doi:10.4158/EP15778.OR
   PubMed Web of Science ®Google Scholar
• Ye S, Ran H, Zhang H, et al. Elevated serum triglycerides are associated with ketosis-prone type 2 diabetes in young individuals. Diabetes Metab Syndr Obes. 2021;14:497–504. doi:10.2147/DMSO.S296085
   PubMed Web of Science ®Google Scholar
• Bonora BM, Avogaro A, Fadini GP. Euglycemic ketoacidosis. Curr Diab Rep. 2020;20(7):25. doi:10.1007/s11892-020-01307-x
   Web of Science ®Google Scholar
• Fayfman M, Pasquel FJ, Umpierrez GE. Management of hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. Med Clin North Am. 2017;101(3):587–606. doi:10.1016/j.mcna.2016.12.011
   PubMed Web of Science ®Google Scholar
• Hough FS, Pierroz DD, Cooper C, Ferrari SL, _ _. Mechanisms in endocrinology: mechanisms and evaluation of bone fragility in type 1 diabetes mellitus. Eur J Endocrinol. 2016;174(4):R127–R138. doi:10.1530/EJE-15-0820
   Web of Science ®Google Scholar
• Hamann C, Kirschner S, Günther KP, Hofbauer LC. Bone, sweet bone–osteoporotic fractures in diabetes mellitus. Nat Rev Endocrinol. 2012;8(5):297–305. doi:10.1038/nrendo.2011.233
   PubMed Web of Science ®Google Scholar
• Cooper ID, Brookler KH, Crofts CAP. Rethinking fragility fractures in type 2 diabetes: the link between hyperinsulinaemia and osteofragilitas. Biomedicines. 2021;9(9):1165. doi:10.3390/biomedicines9091165
   Web of Science ®Google Scholar
• Walsh JS, Vilaca T. Obesity, type 2 diabetes and bone in adults. Calcif Tissue Int. 2017;100(5):528–535. doi:10.1007/s00223-016-0229-0
   PubMed Web of Science ®Google Scholar
• Tittel SR, Sondern KM, Weyer M, et al. Multicentre analysis of hyperglycaemic hyperosmolar state and diabetic ketoacidosis in type 1 and type 2 diabetes. Acta Diabetol. 2020;57(10):1245–1253. doi:10.1007/s00592-020-01538-0
   Web of Science ®Google Scholar
• Martin HE, Wertman M. Serum potassium, magnesium, and calcium levels in diabetic acidosis. J Clin Invest. 1947;26(2):217–228. doi:10.1172/JCI101799
   PubMed Web of Science ®Google Scholar
• Huynh T, Greer RM, Nyunt O, et al. The association between ketoacidosis and 25 (OH)-vitamin D levels at presentation in children with type 1 diabetes mellitus. Pediatr Diabetes. 2009;10(1):38–43. doi:10.1111/j.1399-5448.2008.00439.x
   Web of Science ®Google Scholar
• Topaloglu AK, Yildizdas D, Yilmaz HL, Mungan NO, Yuksel B, Ozer G. Bone calcium changes during diabetic ketoacidosis: a comparison with lactic acidosis due to volume depletion. Bone. 2005;37(1):122–127. doi:10.1016/j.bone.2005.03.012
   Web of Science ®Google Scholar
• Korpi-Steiner N, Milhorn D, Hammett-Stabler C. Osteoporosis in men. Clin Biochem. 2014;47(10–11):950–959. doi:10.1016/j.clinbiochem.2014.03.026
   Web of Science ®Google Scholar
• Sharma D, Larriera AI, Palacio-Mancheno PE, et al. The effects of estrogen deficiency on cortical bone microporosity and mineralization. Bone. 2018;110:1–10. doi:10.1016/j.bone.2018.01.019
   PubMed Web of Science ®Google Scholar
• Khosla S, Monroe DG. Regulation of bone metabolism by sex steroids. Cold Spring Harb Perspect Med. 2018;8(1):a031211. doi:10.1101/cshperspect.a031211
   Web of Science ®Google Scholar
• Shao P, Guo S, Li G, Qin D, Li S, Luan Y. Determinants of deranged thyroid function parameters in children admitted for management of diabetic ketoacidosis/diabetic ketosis. BMC Endocr Disord. 2020;20(1):135. doi:10.1186/s12902-020-00616-2
   Web of Science ®Google Scholar
• Fliers E, Boelen A. An update on non-thyroidal illness syndrome. J Endocrinol Invest. 2021;44(8):1597–1607. doi:10.1007/s40618-020-01482-4
   PubMed Web of Science ®Google Scholar
• Halsall DJ, Oddy S. Clinical and laboratory aspects of 3,3’,5’-triiodothyronine (reverse T3). Ann Clin Biochem. 2021;58(1):29–37. doi:10.1177/0004563220969150
   Web of Science ®Google Scholar
• Liu C, Pan J, Wen S, et al. Low TSH levels within euthyroid range could play a negative role on bone mineral density in postmenopausal women with type 2 diabetes. Diabetes Metab Syndr Obes. 2021;14:2349–2355. doi:10.2147/DMSO.S307633
   Web of Science ®Google Scholar